Skip to main content
logo
CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
1.645
-0.105 (-6.00%)
Oct 30, 2026, 9:38 AM EDT - Market open

CervoMed Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.334.019.747.14--
Revenue Growth
-95.74%-58.86%36.29%---
Gross Profit
-21-17.81-9.06-1.29-1.34-
Operating Income
-31.16-28.29-18.23-7.81-3.48-5.04
Net Income
-30.35-26.97-16.29-2.17-5.8-4.14
Earnings Per Share
-3.19-2.98-2.02-0.82-11.20-0.92
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
24.9420.8638.927.794.096.67
Total Debt
----12.4110.03
Net Cash (Debt)
24.9420.8638.927.79-8.32-3.36
Net Cash Growth
-25.63%-46.39%399.46%---
Net Cash Per Share
2.622.314.822.93-16.06-0.75

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-27.98-23.45-16.53-7.45-2.57-4.13
Free Cash Flow
-27.98-23.45-16.53-7.45-2.57-4.13
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---93.04%-18.11%--
Operating Margin
-9406.96%-706.22%-187.18%-109.35%--
Pretax Margin
-9160.94%-673.06%-167.29%-30.40%--
Profit Margin
-9160.94%-673.06%-167.29%-30.40%--

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
79.8618.241.986.06--